{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:44:36Z","timestamp":1793108676025,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T00:00:00Z","timestamp":1574812800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T00:00:00Z","timestamp":1574812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010002","name":"Ministry of Education","doi-asserted-by":"publisher","award":["DP2-107-21121-0-04"],"award-info":[{"award-number":["DP2-107-21121-0-04"]}],"id":[{"id":"10.13039\/100010002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010002","name":"Ministry of Education","doi-asserted-by":"publisher","award":["DP2-108-21121-01-O-04-01"],"award-info":[{"award-number":["DP2-108-21121-01-O-04-01"]}],"id":[{"id":"10.13039\/100010002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010002","name":"Ministry of Education","doi-asserted-by":"publisher","award":["DP2-108-21121-01-O-04-03"],"award-info":[{"award-number":["DP2-108-21121-01-O-04-03"]}],"id":[{"id":"10.13039\/100010002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 108-2314-B-038-096"],"award-info":[{"award-number":["MOST 108-2314-B-038-096"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Taipei Medical University and Shuang Ho Hospital","award":["105TMU-SHH-09"],"award-info":[{"award-number":["105TMU-SHH-09"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Ovarian cancer (OC) is the most lethal gynecological cancer, worldwide, largely due to its vague and nonspecific early stage symptoms, resulting in most tumors being found at advanced stages. Moreover, due to its relative rarity, there are currently no satisfactory methods for OC screening, which remains a controversial and cost-prohibitive issue. Here, we demonstrate that Papanicolaou test (Pap test) cervical scrapings, instead of blood, can reveal genetic\/epigenetic information for OC detection, using specific and sensitive DNA methylation biomarkers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We analyzed the methylomes of tissues (50 OC tissues versus 6 normal ovarian epithelia) and cervical scrapings (5 OC patients versus 10 normal controls), and integrated public methylomic datasets, including 79 OC tissues and 6 normal tubal epithelia. Differentially methylated genes were further classified by unsupervised hierarchical clustering, and each candidate biomarker gene was verified in both OC tissues and cervical scrapings by either quantitative methylation-specific polymerase chain reaction (qMSP) or bisulfite pyrosequencing. A risk-score by logistic regression was generated for clinical application.<\/jats:p>\n                <jats:p>One hundred fifty-one genes were classified into four clusters, and nine candidate hypermethylated genes from these four clusters were selected. Among these, four genes fulfilled our selection criteria and were validated in training and testing set, respectively. The OC detection accuracy was demonstrated by area under the receiver operating characteristic curves (AUCs) in 0.80\u20130.83 of <jats:italic>AMPD3<\/jats:italic>, 0.79\u20130.85 of <jats:italic>AOX1<\/jats:italic>, 0.78\u20130.88 of <jats:italic>NRN1<\/jats:italic>, and 0.82\u20130.85 of <jats:italic>TBX15<\/jats:italic>. From this, we found OC-risk score, equation generated by logistic regression in training set and validated an OC-associated panel comprising <jats:italic>AMPD3<\/jats:italic>, <jats:italic>NRN1<\/jats:italic>, and <jats:italic>TBX15<\/jats:italic>, reaching a sensitivity of 81%, specificity of 84%, and OC detection accuracy of 0.91 (95% CI, 0.82\u20131) in testing set.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Ovarian cancer detection from cervical scrapings is feasible, using particularly promising epigenetic biomarkers such as <jats:italic>AMPD3\/NRN1\/TBX15<\/jats:italic>. Further validation is warranted.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13148-019-0773-3","type":"journal-article","created":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T13:02:34Z","timestamp":1574859754000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Ovarian cancer detection by DNA methylation in cervical scrapings"],"prefix":"10.1186","volume":"11","author":[{"given":"Tzu-I","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Lan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Hsuan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Peng","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Hsuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8048-3943","authenticated-orcid":false,"given":"Hung-Cheng","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,27]]},"reference":[{"key":"773_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.20892\/j.issn.2095-3941.2016.0084","volume":"14","author":"BM Reid","year":"2017","unstructured":"Reid BM, Permuth JB, Sellers TA. Epidemiology of ovarian cancer: a review. Cancer biology & medicine. 2017;14:9\u201332.","journal-title":"Cancer biology & medicine"},{"key":"773_CR2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7\u201330.","journal-title":"CA Cancer J Clin"},{"key":"773_CR3","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1001\/jama.2011.766","volume":"305","author":"SS Buys","year":"2011","unstructured":"Buys SS, Partridge E, Black A, Johnson CC, Lamerato L, Isaacs C, Reding DJ, Greenlee RT, Yokochi LA, Kessel B, et al. Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening randomized controlled trial. JAMA. 2011;305:2295\u2013303.","journal-title":"JAMA"},{"key":"773_CR4","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.ajog.2015.03.044","volume":"213","author":"FR Nezhat","year":"2015","unstructured":"Nezhat FR, Apostol R, Nezhat C, Pejovic T. New insights in the pathophysiology of ovarian cancer and implications for screening and prevention. Am J Obstet Gynecol. 2015;213:262\u20137.","journal-title":"Am J Obstet Gynecol"},{"key":"773_CR5","doi-asserted-by":"crossref","unstructured":"van Driel WJ, Koole SN, Sikorska K Schagen van Leeuwen JH, Schreuder HWR, Hermans RHM, de Hingh I, van der Velden J, Arts HJ, Massuger L, et al: Hyperthermic intraperitoneal chemotherapy in ovarian cancer. N Engl J Med 2018, 378:230\u2013240.","DOI":"10.1056\/NEJMoa1708618"},{"key":"773_CR6","first-page":"2474","volume":"307","author":"A Slomski","year":"2012","unstructured":"Slomski A. Screening women for ovarian cancer still does more harm than good. Jama. 2012;307:2474\u20135.","journal-title":"Jama"},{"key":"773_CR7","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/S0140-6736(15)01224-6","volume":"387","author":"IJ Jacobs","year":"2016","unstructured":"Jacobs IJ, Menon U, Ryan A, Gentry-Maharaj A, Burnell M, Kalsi JK, Amso NN, Apostolidou S, Benjamin E, Cruickshank D, et al. Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. Lancet. 2016;387:945\u201356.","journal-title":"Lancet"},{"key":"773_CR8","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1093\/jnci\/djr359","volume":"103","author":"N Urban","year":"2011","unstructured":"Urban N, Thorpe JD, Bergan LA, Forrest RM, Kampani AV, Scholler N, O'Briant KC, Anderson GL, Cramer DW, Berg CD, et al. Potential role of HE4 in multimodal screening for epithelial ovarian cancer. J Natl Cancer Inst. 2011;103:1630\u20134.","journal-title":"J Natl Cancer Inst"},{"key":"773_CR9","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1097\/IGC.0000000000000737","volume":"26","author":"AR Simmons","year":"2016","unstructured":"Simmons AR, Clarke CH, Badgwell DB, Lu Z, Sokoll LJ, Lu KH, Zhang Z, Bast RC Jr, Skates SJ. Validation of a biomarker panel and longitudinal biomarker performance for early detection of ovarian cancer. Int J Gynecol Cancer. 2016;26:1070\u20137.","journal-title":"Int J Gynecol Cancer"},{"key":"773_CR10","doi-asserted-by":"publisher","first-page":"4664","DOI":"10.1158\/1078-0432.CCR-16-0316","volume":"22","author":"KL Terry","year":"2016","unstructured":"Terry KL, Schock H, Fortner RT, Husing A, Fichorova RN, Yamamoto HS, Vitonis AF, Johnson T, Overvad K, Tjonneland A, et al. A prospective evaluation of early detection biomarkers for ovarian cancer in the European EPIC cohort. Clin Cancer Res. 2016;22:4664\u201375.","journal-title":"Clin Cancer Res"},{"key":"773_CR11","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1002\/cncr.24997","volume":"116","author":"AA Kamat","year":"2010","unstructured":"Kamat AA, Baldwin M, Urbauer D, Dang D, Han LY, Godwin A, Karlan BY, Simpson JL, Gershenson DM, Coleman RL, et al. Plasma cell-free DNA in ovarian cancer: an independent prognostic biomarker. Cancer. 2010;116:1918\u201325.","journal-title":"Cancer"},{"key":"773_CR12","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1200\/JCO.2012.45.2011","volume":"32","author":"LA Diaz Jr","year":"2014","unstructured":"Diaz LA Jr, Bardelli A. Liquid biopsies: genotyping circulating tumor DNA. J Clin Oncol. 2014;32:579\u201386.","journal-title":"J Clin Oncol"},{"key":"773_CR13","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1158\/2159-8290.CD-13-1014","volume":"4","author":"DA Haber","year":"2014","unstructured":"Haber DA, Velculescu VE. Blood-based analyses of cancer: circulating tumor cells and circulating tumor DNA. Cancer discovery. 2014;4:650\u201361.","journal-title":"Cancer discovery"},{"key":"773_CR14","doi-asserted-by":"publisher","first-page":"311","DOI":"10.2217\/epi.14.20","volume":"6","author":"T Wittenberger","year":"2014","unstructured":"Wittenberger T, Sleigh S, Reisel D, Zikan M, Wahl B, Alunni-Fabbroni M, Jones A, Evans I, Koch J, Paprotka T, et al. DNA methylation markers for early detection of women's cancer: promise and challenges. Epigenomics. 2014;6:311\u201327.","journal-title":"Epigenomics"},{"key":"773_CR15","doi-asserted-by":"publisher","first-page":"e0155495","DOI":"10.1371\/journal.pone.0155495","volume":"11","author":"Q Zhou","year":"2016","unstructured":"Zhou Q, Li W, Leng B, Zheng W, He Z, Zuo M, Chen A. Circulating cell free DNA as the diagnostic marker for ovarian cancer: a systematic review and meta-analysis. PLoS One. 2016;11:e0155495.","journal-title":"PLoS One"},{"key":"773_CR16","doi-asserted-by":"publisher","first-page":"224ra224","DOI":"10.1126\/scitranslmed.3007094","volume":"6","author":"C Bettegowda","year":"2014","unstructured":"Bettegowda C, Sausen M, Leary RJ, Kinde I, Wang Y, Agrawal N, Bartlett BR, Wang H, Luber B, Alani RM, et al. Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med. 2014;6:224ra224.","journal-title":"Sci Transl Med"},{"key":"773_CR17","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12916-016-0667-6","volume":"14","author":"PA Cohen","year":"2016","unstructured":"Cohen PA, Flowers N, Tong S, Hannan N, Pertile MD, Hui L. Abnormal plasma DNA profiles in early ovarian cancer using a non-invasive prenatal testing platform: implications for cancer screening. BMC Med. 2016;14:126.","journal-title":"BMC Med"},{"key":"773_CR18","doi-asserted-by":"publisher","first-page":"167ra164","DOI":"10.1126\/scitranslmed.3004952","volume":"5","author":"I Kinde","year":"2013","unstructured":"Kinde I, Bettegowda C, Wang Y, Wu J, Agrawal N, Shih Ie M, Kurman R, Dao F, Levine DA, Giuntoli R, et al. Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers. Sci Transl Med. 2013;5:167ra164.","journal-title":"Sci Transl Med"},{"key":"773_CR19","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.cancergen.2011.09.004","volume":"204","author":"JI Weberpals","year":"2011","unstructured":"Weberpals JI, Koti M, Squire JA. Targeting genetic and epigenetic alterations in the treatment of serous ovarian cancer. Cancer Gene Ther. 2011;204:525\u201335.","journal-title":"Cancer Gene Ther"},{"key":"773_CR20","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/jcmm.12771","volume":"20","author":"H Bai","year":"2016","unstructured":"Bai H, Cao D, Yang J, Li M, Zhang Z, Shen K. Genetic and epigenetic heterogeneity of epithelial ovarian cancer and the clinical implications for molecular targeted therapy. J Cell Mol Med. 2016;20:581\u201393.","journal-title":"J Cell Mol Med"},{"key":"773_CR21","doi-asserted-by":"crossref","unstructured":"Longacre M, Snyder NA, Housman G, Leary M, Lapinska K, Heerboth S, Willbanks A, Sarkar S. A comparative analysis of genetic and epigenetic events of breast and ovarian cancer related to tumorigenesis. Int J Mol Sci. 2016;17.","DOI":"10.3390\/ijms17050759"},{"key":"773_CR22","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.3802\/jgo.2018.29.e17","volume":"29","author":"C-C Chang","year":"2018","unstructured":"Chang C-C, Wang H-C, Liao Y-P, Chen Y-C, Weng Y-C, Yu M-H, Lai H-C. The feasibility of detecting endometrial and ovarian cancer using DNA methylation biomarkers in cervical scrapings. J Gynecol Oncol. 2018;29:e17.","journal-title":"J Gynecol Oncol"},{"key":"773_CR23","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.ygyno.2013.11.030","volume":"132","author":"U Menon","year":"2014","unstructured":"Menon U, Griffin M, Gentry-Maharaj A. Ovarian cancer screening--current status, future directions. Gynecol Oncol. 2014;132:490\u20135.","journal-title":"Gynecol Oncol"},{"key":"773_CR24","doi-asserted-by":"crossref","unstructured":"Advancing Cancer Screening with Liquid Biopsies. Cancer discov. 2018;8:256.","DOI":"10.1158\/2159-8290.CD-NB2018-009"},{"key":"773_CR25","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1126\/science.aar3247","volume":"359","author":"JD Cohen","year":"2018","unstructured":"Cohen JD, Li L, Wang Y, Thoburn C, Afsari B, Danilova L, Douville C, Javed AA, Wong F, Mattox A, et al. Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science. 2018;359:926\u201330.","journal-title":"Science"},{"key":"773_CR26","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/PGP.0b013e31826a6446","volume":"32","author":"C Bagby","year":"2013","unstructured":"Bagby C, Ronnett BM, Yemelyanova A, Maleki Z, Kuhn E, Vang R. Clinically occult tubal and ovarian high-grade serous carcinomas presenting in uterine samples: diagnostic pitfalls and clues to improve recognition of tumor origin. Int J Gynecol Pathol. 2013;32:433\u201343.","journal-title":"Int J Gynecol Pathol"},{"key":"773_CR27","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1373\/clinchem.2013.204933","volume":"60","author":"J Bakkum-Gamez","year":"2014","unstructured":"Bakkum-Gamez J, Dowdy S. Retooling the pap smear for ovarian and endometrial cancer detection. Clin Chem. 2014;60:22\u20134.","journal-title":"Clin Chem"},{"key":"773_CR28","doi-asserted-by":"crossref","unstructured":"Wang Y, Li L, Douville C, Cohen JD, Yen TT, Kinde I, Sundfelt K, Kjaer SK, Hruban RH, Shih IM, et al. Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers. Sci Transl Med. 2018;10.","DOI":"10.1126\/scitranslmed.aap8793"},{"key":"773_CR29","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/BF01880656","volume":"16","author":"M Gross","year":"1994","unstructured":"Gross M. Molecular biology of AMP deaminase deficiency. Pharm World Sci. 1994;16:55\u201361.","journal-title":"Pharm World Sci"},{"key":"773_CR30","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s00204-016-1683-1","volume":"90","author":"M Terao","year":"2016","unstructured":"Terao M, Romao MJ, Leimkuhler S, Bolis M, Fratelli M, Coelho C, Santos-Silva T, Garattini E. Structure and function of mammalian aldehyde oxidases. Arch Toxicol. 2016;90:753\u201380.","journal-title":"Arch Toxicol"},{"key":"773_CR31","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s00429-012-0487-1","volume":"219","author":"A Zito","year":"2014","unstructured":"Zito A, Cartelli D, Cappelletti G, Cariboni A, Andrews W, Parnavelas J, Poletti A, Galbiati M. Neuritin 1 promotes neuronal migration. Brain Struct Funct. 2014;219:105\u201318.","journal-title":"Brain Struct Funct"},{"key":"773_CR32","doi-asserted-by":"publisher","first-page":"8054","DOI":"10.1038\/ncomms9054","volume":"6","author":"KY Lee","year":"2015","unstructured":"Lee KY, Singh MK, Ussar S, Wetzel P, Hirshman MF, Goodyear LJ, Kispert A, Kahn CR. Tbx15 controls skeletal muscle fibre-type determination and muscle metabolism. Nat Commun. 2015;6:8054.","journal-title":"Nat Commun"},{"issue":"2","key":"773_CR33","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/ijc.31324","volume":"143","author":"PL Liew","year":"2018","unstructured":"Liew PL, Huang RL, Weng YC, Fang CL, Hui-Ming Huang T. Lai HC3. Distinct methylation profile of mucinous ovarian carcinoma reveals susceptibility to proteasome inhibitors. Int J Cancer. 2018;143(2):355\u201367.","journal-title":"Int J Cancer"},{"key":"773_CR34","doi-asserted-by":"publisher","first-page":"624","DOI":"10.4161\/epi.24816","volume":"8","author":"RL Huang","year":"2013","unstructured":"Huang RL, Gu F, Kirma NB, Ruan J, Chen CL, Wang HC, Liao YP, Chang CC, Yu MH, Pilrose JM, et al. Comprehensive methylome analysis of ovarian tumors reveals hedgehog signaling pathway regulators as prognostic DNA methylation biomarkers. Epigenetics. 2013;8:624\u201334.","journal-title":"Epigenetics"},{"key":"773_CR35","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nature14410","volume":"521","author":"AM Patch","year":"2015","unstructured":"Patch AM, Christie EL, Etemadmoghadam D, Garsed DW, George J, Fereday S, Nones K, Cowin P, Alsop K, Bailey PJ, et al. Whole-genome characterization of chemoresistant ovarian cancer. Nature. 2015;521:489\u201394.","journal-title":"Nature"},{"key":"773_CR36","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S1701-2163(15)30659-9","volume":"36","author":"CJ Reade","year":"2014","unstructured":"Reade CJ, McVey RM, Tone AA, Finlayson SJ, McAlpine JN, Fung-Kee-Fung M, Ferguson SE. The fallopian tube as the origin of high grade serous ovarian cancer: review of a paradigm shift. J Obstet Gynaecol Can. 2014;36:133\u201340.","journal-title":"J Obstet Gynaecol Can"},{"key":"773_CR37","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1158\/1541-7786.MCR-16-0097","volume":"14","author":"D Klinkebiel","year":"2016","unstructured":"Klinkebiel D, Zhang W, Akers SN, Odunsi K, Karpf AR. DNA methylome analyses implicate fallopian tube epithelia as the origin for high-grade serous ovarian cancer. Mol Cancer Res. 2016;14:787\u201394.","journal-title":"Mol Cancer Res"},{"key":"773_CR38","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S0076-6879(06)11009-5","volume":"411","author":"AI Saeed","year":"2006","unstructured":"Saeed AI, Bhagabati NK, Braisted JC, Liang W, Sharov V, Howe EA, Li J, Thiagarajan M, White JA, Quackenbush J. TM4 microarray software suite. Methods Enzymol. 2006;411:134\u201393.","journal-title":"Methods Enzymol"},{"key":"773_CR39","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W Huang da","year":"2009","unstructured":"Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44\u201357.","journal-title":"Nat Protoc"},{"key":"773_CR40","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28:27\u201330.","journal-title":"Nucleic Acids Res"},{"key":"773_CR41","doi-asserted-by":"publisher","first-page":"D691","DOI":"10.1093\/nar\/gkq1018","volume":"39","author":"D Croft","year":"2011","unstructured":"Croft D, O'Kelly G, Wu G, Haw R, Gillespie M, Matthews L, Caudy M, Garapati P, Gopinath G, Jassal B, et al. Reactome: a database of reactions, pathways and biological processes. Nucleic Acids Res. 2011;39:D691\u20137.","journal-title":"Nucleic Acids Res"},{"key":"773_CR42","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1158\/1078-0432.CCR-16-0863","volume":"23","author":"RL Huang","year":"2017","unstructured":"Huang RL, Su PH, Liao YP, Wu TI, Hsu YT, Lin WY, Wang HC, Weng YC, Ou YC, Huang TH, Lai HC. Integrated epigenomics analysis reveals a DNA methylation panel for endometrial cancer detection using cervical scrapings. Clin Cancer Res. 2017;23:263\u201372.","journal-title":"Clin Cancer Res"},{"key":"773_CR43","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1093\/aje\/kwu140","volume":"180","author":"GC Smith","year":"2014","unstructured":"Smith GC, Seaman SR, Wood AM, Royston P, White IR. Correcting for optimistic prediction in small data sets. Am J Epidemiol. 2014;180:318\u201324.","journal-title":"Am J Epidemiol"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-019-0773-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13148-019-0773-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-019-0773-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T00:14:51Z","timestamp":1606349691000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalepigeneticsjournal.biomedcentral.com\/articles\/10.1186\/s13148-019-0773-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,27]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["773"],"URL":"https:\/\/doi.org\/10.1186\/s13148-019-0773-3","relation":{},"ISSN":["1868-7075","1868-7083"],"issn-type":[{"value":"1868-7075","type":"print"},{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,27]]},"assertion":[{"value":"16 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Institutional Review Board of Taipei Medical University approved our protocol (#201405025), and each participant gave written informed consent upon recruitment.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"166"}}